首页> 外文期刊>Ethnicity & disease. >ACE inhibitor and ARB medication use among Medicaid enrollees with diabetes.
【24h】

ACE inhibitor and ARB medication use among Medicaid enrollees with diabetes.

机译:在患有Medicaid的糖尿病患者中使用ACE抑制剂和ARB药物。

获取原文
获取原文并翻译 | 示例
           

摘要

To examine ace-inhibitor (ACEI) and angiotensin receptor blockers (ARB) prescription and adherence patterns by race in diabetic public aid recipients. DESIGN, PARTICIPANTS, AND MEASURES: We analyzed prescription records of 27,529 adults aged 18-64 with diabetes who had at least one clinical indication for receiving an ACEI/ ARB prescription and were enrolled in the State of Illinois public aid program during 2007. We calculated proportion of days covered (PDC) to assess adherence. Multivariate models adjusted for age, sex, ACEI/ARB indication, and any significant interaction terms.Only 47.4% of individuals with at least one indication for ACEI/ARB had filled an ACEI/ARB prescription. African American men were more likely than Caucasian men to ever fill an ACEI/ARB prescription (adjusted odds ratio, [AOR] [95% CI] 1.69 [1.55-1.83]). Hispanic English and Spanish speaking men were also more likely than Caucasian men to ever fill an ACEI/ARB prescription (AOR [95% CI] 1.37 [1.16-1.62] and 1.27 [1.05-1.53], respectively). Similarly, African American and Hispanic English and Spanish speaking women were more likely than Caucasian women to ever fill an ACEI/ARB prescription (AOR [95% CI] 1.70 [1.59-1.81], 1.55 (1.36-1.76), and 1.98 (1.73-2.28), respectively. However, African Americans and Hispanics were less likely than Caucasians to achieve a PDC> or =80%. Compared to Caucasians, Hispanic Spanish speakers were the least likely to be adherent (AOR [95% CI] .49 [.41-.58]). Furthermore, older individuals were more likely to achieve a PDC> or =80% than younger individuals.African Americans and Hispanics with diabetes receiving public aid in Illinois were more likely than Caucasians to have filled at least one ACEI/ARB prescription. However, they were less adherent with these medications. Future studies should assess barriers to medication adherence in this population.
机译:通过种族来检查糖尿病公共援助接受者中的ACE抑制剂(ACEI)和血管紧张素受体阻滞剂(ARB)处方和依从性。设计,参与者和措施:我们分析了27,529名18-64岁糖尿病成年人的处方记录,这些成年人至少具有一种接受ACEI / ARB处方的临床指征,并于2007年参加了伊利诺伊州公共援助计划。我们进行了计算评估遵守率的涵盖天数(PDC)的比例。根据年龄,性别,ACEI / ARB适应症和任何重要的交互作用条件对多元模型进行调整。只有47.4%的患者至少具有一种ACEI / ARB适应症的个人填写了ACEI / ARB处方与白人男子相比,非裔美国人更有可能填写ACEI / ARB处方(调整后的赔率,[AOR] [95%CI] 1.69 [1.55-1.83])。西班牙裔英语和西班牙语的男性也比白种人男性更有可能接受ACEI / ARB处方(AOR [95%CI] 1.37 [1.16-1.62]和1.27 [1.05-1.53​​])。同样,非洲裔美国人和西班牙裔英语和西班牙语的女性比白人女性更有可能填写ACEI / ARB处方(AOR [95%CI] 1.70 [1.59-1.81],1.55(1.36-1.76)和1.98(1.73) -2.28)。然而,非裔美国人和西班牙裔美国人达到PDC>或= 80%的可能性比白种人高。与白种人相比,西班牙裔说西班牙语的人最不可能遵守(AOR [95%CI] .49 [.41-.58])。此外,老年人比年轻人更容易实现PDC>或= 80%。在伊利诺伊州接受非洲裔美国人援助的非裔美国人和西班牙裔美国人比白种人更容易满足至少一种ACEI / ARB处方药,但是它们对这些药物的依从性较差,未来的研究应评估该人群中药物依从性的障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号